Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paliperidone ER for Depressive Symptoms in Schizophrenia
NCT01399450Phase 4Completed
- Sponsor
- Seoul National University Hospital
- Start
- Aug 2011
- Primary completion
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of paliperidone in schizophrenia, sponsored by Seoul National University Hospital. Primary endpoint: Montgomery Asberg Depression Rating Scale at 8 weeks. Started Aug 2011; status: completed.
02
Drugs
paliperidone
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT01399450.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01399450.